Atara Biotherapeutics (ATRA) EBIT Margin (QoQ) (2021 - 2026)
Powered by 
Analysis
Atara Biotherapeutics (ATRA) EBIT Margin (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.24 Bn | 9.40 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.67 Bn | 3.37 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.55 Bn | 2.59 Bn | 251.50 Mn |
| 5 | uniQure | 2.96 Bn | 2.96 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Atara Biotherapeutics | 148.53 Mn | 131.97 Mn | 439,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9,630.00 |
| Mar 31, 2026 | -49,222.00 |
| Dec 31, 2025 | -5,719.00 |
| Sep 30, 2025 | -12,169.00 |
| Jun 30, 2025 | -2,134.00 |
| Mar 31, 2025 | 7,679.00 |
| Dec 31, 2024 | 1,688.00 |
| Sep 30, 2024 | 952.00 |
| Jun 30, 2024 | 5,056.00 |
| Mar 31, 2024 | 129,599.00 |
| Dec 31, 2023 | 184,573.00 |
| Sep 30, 2023 | 420,634.00 |
| Jun 30, 2023 | -134,335.00 |
| Mar 31, 2023 | 2.43 Mn |
| Dec 31, 2022 | -2.86 Mn |
| Sep 30, 2022 | -183,548.00 |
| Jun 30, 2022 | 114,388.00 |
| Mar 31, 2022 | 3,127.00 |
| Dec 31, 2021 | 34,191.00 |
| Sep 30, 2021 | 59,123.00 |